| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a00e0a192c4622c5028c56cf87c1e895 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0036 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 |
| filingDate |
1989-07-11^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63dee5163bdd0c47dd79fa3e40d18749 |
| publicationDate |
1990-10-31^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DD-283932-A5 |
| titleOfInvention |
PROCESS FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OF SEXUALLY TRANSFERRED DISEASES |
| abstract |
In the process for the preparation of a pharmaceutical composition for the prevention of sexually transmitted diseases and for contact with a mucous membrane, at least one active substance is used against the viruses or bacteria responsible for the sexually transmitted diseases, a penetration inhibitor for the active substances through the mucous membrane and a pharmaceutically acceptable suitable carrier combined. The penetration inhibitor may desirably form a film with which the drug (s) are associated. The pharmaceutical composition thus prepared can be combined with a vaginal tampon in which it penetrates by capillary action. pharmaceutical composition; sexually transmitted diseases; contact; mucosa; Penetration inhibitor; agents; Carrier; Vaginaltampon} |
| priorityDate |
1988-07-11^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |